"Human papillomavirus 16" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA.
Descriptor ID |
D052162
|
MeSH Number(s) |
B04.280.210.655.050.616 B04.613.204.655.050.616
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human papillomavirus 16".
Below are MeSH descriptors whose meaning is more specific than "Human papillomavirus 16".
This graph shows the total number of publications written about "Human papillomavirus 16" by people in this website by year, and whether "Human papillomavirus 16" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 3 | 2 | 5 |
2017 | 1 | 0 | 1 |
2019 | 0 | 2 | 2 |
2020 | 1 | 0 | 1 |
2021 | 0 | 2 | 2 |
2022 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human papillomavirus 16" by people in Profiles.
-
International Anal Neoplasia Society's consensus guidelines for anal cancer screening. Int J Cancer. 2024 May 15; 154(10):1694-1702.
-
Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers. Cancer Immunol Res. 2022 02; 10(2):259-271.
-
Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults. JNCI Cancer Spectr. 2021 12; 5(6).
-
Comparing Anal Cancer Screening Algorithms Using Cytology and Human Papillomavirus DNA Testing in 3 High-Risk Populations. J Infect Dis. 2021 09 01; 224(5):881-888.
-
HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout. Virology. 2021 02; 554:9-16.
-
Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women. JAMA Netw Open. 2019 12 02; 2(12):e1918571.
-
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer. J Immunother Cancer. 2019 09 18; 7(1):252.
-
The Role of DCT in HPV16 Infection of HaCaTs. PLoS One. 2017; 12(1):e0170158.
-
A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16. J Virol. 2015 Sep; 89(17):9103-14.
-
Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015 Aug; 51(8):727-30.